Robert Marsh to Glucuronosyltransferase
This is a "connection" page, showing publications Robert Marsh has written about Glucuronosyltransferase.
Connection Strength
0.106
-
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer. J Clin Oncol. 2014 Aug 01; 32(22):2328-34.
Score: 0.106